Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Download PDF

Role of intravoxel incoherent motion MRI in diagnosis and assessment of invasiveness of urothelial bladder carcinoma

Egyptian Journal of Radiology and Nuclear Medicine volume 55, Article number: 40 (2024) Cite this article

Abstract

Background

Urinary bladder cancer is a common malignancy. Preoperative accurate judgment of the degree of tissue invasion is crucial to determine the plan of therapy. We aimed in the current study to evaluate the role of intravoxel incoherent motion (IVIM) MRI and apparent diffusion coefficient (ADC) map in differentiating muscle invasive from non-muscle invasive carcinomas.

Results

Values of IVIM-derived true diffusion coefficient (D), pseudo-diffusion coefficient (D*) and perfusion fraction (F) and ADC were lower in muscle invasive carcinomas than non-invasive masses with p values < 0.001 and 0.001, respectively. In MIBC, ADC was (0.9 × 10−3 mm2/s), D was (0.8 × 10−3 mm2/s), D* was (6.9 × 10−3 mm2/s) and F was (16.9%). In NMIBC, ADC was (1 × 10−3 mm2/s), D was (1.1 × 10−3 mm2/s), D* was (10.2 × 10−3 mm2/s) and F was (17.7%). Mass D cut off values, sensitivity and specificity and AUC were < 0.9, 83.93, 96.30 and 0.945, respectively. Mass ADC cut off values, sensitivity and specificity and AUC were < 1.09, 87.50, 51.85 and 0.721, respectively. The degree of agreement between IVIM parameters and the pathological staging was assessed by Kappa test. The best agreement was detected for mass D (K = 0.796), while the mass ADC and wall beside mass D showed moderate and fair agreement (k = 0.418 and 0.325, respectively).

Conclusions

IVIM MRI parameters and ADC map can be utilized to detect the degree of tissue invasion caused by bladder cancer.

Background

Urothelial bladder carcinoma is the fourth most common cancer worldwide in males and ninth one in females. However, It represents the third most common cancer in both genders among Egyptians [1, 2]

Accurate staging of urinary bladder carcinomas using TNM staging system preoperatively is crucial to determine both the patients prognosis and management plans [3, 4]. It can be classified into either non-muscle-invasive bladder cancers (NMIBC) that includes stage Ta and T1 and is treated with transurethral resection of bladder tumor (TURBT) with or without intravesical instillation of chemotherapy and muscle invasive bladder cancers (MIBC) that includes stages T2–T4 and is treated with radical cystectomy with or without chemotherapy [5].

Although TURBT is the current standard tool to determine the pathological subtype, stage and grade of the tumor [4, 6], it has many limitations as it is relatively an invasive procedure and frequently needs to be repeated with wide variability between urologists [7, 8].

The current advancement and availability of multi-parametric magnetic resonance imaging (mp-MRI) techniques provide anatomical information through high-resolution T1 and T2 weighted imaging (WI) in addition to functional information through diffusion-weighted imaging (DWI) and dynamic contrast enhancement (DCE). This allows an accurate evaluation of bladder cancer, staging and grading, before proceeding to invasive cystoscopy [9, 10].

DWI with the calculated apparent diffusion coefficient (ADC), utilizing monoexponential model that depends on the diffusion of water molecules and microcirculation perfusion information, has been used efficiently to determine the degree of invasiveness of bladder cancer [11,12,13]. After introduction of the intravoxel incoherent motion (IVIM) theory with separation of water molecular diffusion from microcirculation using biexponential model [14], the IVIM-derived true diffusion coefficient (D) reflects water molecular diffusion, pseudo-diffusion coefficient (D*) represents the microvascular portion and the perfusion fraction (f) is related to the fractional volume occupied in the voxel by microvascular flowing spins [15].

Predicting pathological grading using IVIM-MRI has been studied in gliomas, hepatocellular carcinoma, breast cancer, and evaluating the effect of chemotherapy on colorectal carcinoma [15,16,17,18]. However, the role of IVIM in bladder cancer is not sufficiently studied; therefore, we conducted the current study to evaluate the use of IVIM derived parameters and ADC values in predicting the invasiveness of bladder urothelial carcinoma and to differentiate MIBC from NMIBC.

Methods

Selection and description of participants

This prospective study was approved by the institutional research and ethical committee of Mansoura University and was approved by the international review board (MS.23.01.2275.RI). Written consents were obtained from all patients prior to examination. It included eighty-three patients with bladder cancer based on clinical suspicion, or ultrasonography findings in the period from January 2023 to July 2023. The study was conducted in Radiology Department (MRI Unit), Urology and Nephrology Center, Mansoura University.

Adequate sample size was calculated using G power program version 3.1.9.4, based on effect size of 0.724, using 2-tailed test, α error = 0.05 and power = 90.0%, the total calculated sample size was 83 cases. Inclusion criteria: Patients with clinical suspicion of urothelial carcinoma based on clinical suspicion (hematuria, dysuria or frequency) or ultrasound findings (focal thickening of bladder wall, mass protruding into the bladder lumen or extending into adjacent tissues in advanced cases). Exclusion criteria: Patients with contraindications to MRI study including patients with cardiac pacemaker, metallic implants, or claustrophobic patients or those received neoadjuvant chemotherapy prior to operation and histopathological assessment. Patients who refused to be enrolled in the study and any low image quality or non-standard scan sequences were excluded as illustrated in the flowchart (Fig. 1). Data regarding age, gender, clinical presentation, results of MRI and histopathological examination and operative management of all cases were collected.

Fig. 1
figure 1

The flow chart of participants in the present study

Full size image

Technical information

Regarding MRI examination, all patients were prepared and examined in the supine position using 3-Tesla MRI machine (Philips Ingenia 3T, Netherlands) with local phased external array coil (18 channels) put on the patient’s abdomen and pelvis. The protocol of MRI examination included high resolution T2WI, DWI with post-processing ADC map (b value = 1000) and IVIM-MRI. IVIM-MRI were performed with multiple b values DWI (b values = 0, 10, 25, 50, 75, 100, 150, 200, 400, 600, 800, 1000, 1400 s/mm2). Gadolinium-based contrast agents were not used in this study due to high resolution images obtained by 3T scanner and no need for analysis of tissue perfusion in this study.

The available experimental evidence shows that deviation of the diffusion model from Gaussian diffusion appeared as a double exponential form when we increase the range of b-values used. Moreover, it was not clear how high the value of b should be to avoid this deviation in the IVIM model after ignoring the contribution of non-Gaussian diffusion [19]. However, many studies concluded that the error of parameter measurement decreases with increasing the number of b-values used [20]. On the other side, much increase in chosen b values increases the acquisition time and is unrealistic to be applied to avoid possible artifacts and patient intolerance [21]. Therefore, we used 13 b-values in the present study to accurately characterize the nature of the studied lesions, although the plausibility still needs further investigation. The used MRI sequences are illustrated in Table 1.

Table 1 bpMRI sequences obtained in all patients
Full size table

Regarding the image analysis, all scans were transferred and reviewed on a picture archiving and communication systems (PACS) (Magic View, GE, Milwaukee, WI, USA). T2-WI followed by Diffusion weighted-MR images followed by IVIM sequences—MR images were interpreted referring to T2-WI image sets and the tumors were assigned a T stage in each sequence. When multiple tumors were present, the highest T stage represented the T stage of the patient as follows:

Biparametric MRI (bpMRI) and VI-RADS score in bladder cancer

We put tumors scoring using appearances in T2WI, DWI images and IVIM parameters to create an overall risk of invasion score. Normal bladder mucosa/inner layer was not seen on T2WI and DWI sequences; however, they were seen as high SI structures on T2WI images and low SI structures on DWI due to edema or inflammation. Normal muscularis propria showed low SI on T2WI images and DWI.

  1. a)

    Qualitative assessment (T2WI and DWI) (Figs. 2 and 3).

    1. 1.

      Assessment for T2WI images: Interruption of the low SI muscular line may suggest muscle invasion. Stage 1: uninterrupted low SI line representing the integrity of muscularis propria (tumor < 1 cm with or without thickened inner layer). Stage 2: uninterrupted low SI line representing the integrity of muscularis propria (tumor > 1 cm with high SI thickened inner layer). Stage 3: uninterrupted low SI line representing the integrity of muscularis propria (tumor > 1 cm without high SI thickened inner layer). Stage 4: interruption of low SI line suggesting extension of the intermediate SI tumor tissue to muscularis propria. Stage 5: extension of intermediate SI tumor to extravesical fat, representing the invasion of the entire bladder wall and extravesical structures.

    2. 2.

      Assessment for DWI/ADC map: On DWI, SI of the lesions identified at b 1000 images, at these images, the tumor is hyperintense on DWI and hypointense on ADC map. Muscularis propria may present intermediate SI, while the inner layer has low SI on DWI. While analyzing DWI, interpretation was referred to T1 and T2WIs and lesions are classified into: DW category 1: muscularis propria with intermediate continuous SI on DWI (lesion < 1 cm, hyperintense on DWI and hypointense on ADC, with or without low SI thickened inner layer on DWI). DW category 2: muscularis propria with continuous intermediate SI on DWI (lesion > 1 cm, hyperintense on DWI and hypointense on ADC, with low SI thickened inner layer on DWI). DW category 3: muscularis propria with continuous intermediate SI on DWI (lesion > 1 cm, hyperintense on DWI and hypointense on ADC, without SI thickened inner layer on DWI). DW category 4: High SI tumor on DWI and low SI tumor on ADC extending focally to muscularis propria. DW category 5: High SI tumor on DWI and low SI tumor on ADC extending to the entire bladder wall and extravesical fat.

  2. b)

    Quantitative assessment (ADC value & IVIM parameters) (Figs. 2 and 3). ADC values were calculated on ADC map by placing region of interest (ROI) on most hypointense areas of the tumors, corresponding normal bladder walls & urine. In addition, the ADC values of wall beside mass were measured. Identification of the pelvic lymph nodes was performed according to their sites. Regarding IVIM parameters: the D, D* and F were measured and assessed for the mass and wall beside mass (Table 4) in the same way as before using their maps.

  3. c)

    Final scoring A five-point VI-RADS score is generated using the individual T2WI stage, DWI categories, and IVIM parameters suggesting the probability of muscle invasion: VI-RADS 1 (muscle invasion is highly unlikely): T2WI Stage I, DW category 1 and ADC, D, D* and F measure more than (1 × 10−3 mm2/s, 1.1 × 10−3 mm2/s, 10.2 × 10−3 mm2/s and 17.7%, respectively). VI-RADS 2 (muscle invasion is unlikely to be present): T2WI satge2 and DW category 2 and ADC, D, D* and F measure more than (1 × 10−3 mm2/s, 1.1 × 10−3 mm2/s, 10.2 × 10−3 mm2/s and 17.7% respectively). VI-RADS 3 (the presence of muscle invasion is equivocal): T2WI stage 3 and DW category 3; SC category 3 and ADC, D, D* and F measure about (1 × 10−3 mm2/s, 1.1 × 10−3 mm2/s, 10.2 × 10−3 mm2/s and 17.7% respectively). VI-RADS 4 (muscle invasion is likely): T2WI stage 4 and/or DW category 4 and ADC, D, D* and F measure about (0.9 × 10−3 mm2/s, 0.8 × 10−3 mm2/s, 6.9 × 10−3 mm2/s and 16.9% respectively). VI-RADS 5 (invasion of muscle and beyond the bladder is likely): at least T2 stage 5 plus DW category 5 and ADC, D, D* and F measure less than (0.9 × 10−3 mm2/s, 0.8 × 10−3 mm2/s, 6.9 × 10−3 mm2/s and 16.9%, respectively).

Fig. 2
figure 2

A 63-year-old male patient presented with NMIBC arising from posterior wall of urinary bladder. A Axial T2WI showing small polypoid mass. B Axial DWI showing restricted diffusion in the mass with no extension to the perivesical fat (b = 1000 s/mm2). C ADC value of urinary bladder mass = 0.96 × 10−3 mm2/s, consistent with low grade bladder carcinoma. D, E and F showing D, D* and F maps with quantitative values were measured as 0.91 × 10−3 mm2/s, 5 × 10−3 mm2/s and 0.29, respectively

Full size image
Fig. 3
figure 3

A 62-year-old female patient with MIBC arising from both anterolateral walls of urinary bladder. A Axial T2WI showing two polypoid solid masses. B Axial DWI showing restricted diffusion in the masses with infiltration of perivesical fat (b = 1000 s/mm2). C ADC value of urinary bladder mass = 0.73 × 10−3 mm2/s, consistent with high grade bladder carcinoma. D, E and F showing D, D* and F maps with quantitative values were measured as 0.77 × 10−3 mm2/s, 5 × 10−3 mm2/s and 0.08, respectively

Full size image

Pathological diagnosis

All diagnosed lesions were biopsied either by TURBT or by radical cystectomy and urinary diversion after diagnostic MRI examinations and underwent histopathological evaluation for definitive diagnosis and assess the degree of muscle invasion, to differentiate MIBC from NMIBC.

Statistics

The collected data was revised, coded, and tabulated using the Statistical package for Social Science (IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp.). The normality of data distribution was assessed by Kolmogorov–Smirnov test. Numerical data were presented as either Mean and Standard deviation (± SD) or Median and interquartile range (IQR), while non-numerical data were presented as frequency and percentage. Student's t-test was used to compare means of the two studied groups. Mann–Whitney Test (U test) was used to assess the statistical significance of difference of a nonparametric variable between two study groups. Chi-Square test was used to examine the relationship between two qualitative variables.

The ROC curve (receiver operating characteristic) provides a useful way to evaluate the sensitivity and specificity for quantitative diagnostic measures that categorize cases into one of two groups. The optimum cut off point was defined as that which maximized the AUC value. AUC greater than 0.9 has high accuracy, while 0.7–0.9 indicates moderate accuracy, 0.5–0.7 indicates low accuracy and 0.5 a chance result. The kappa statistic was calculated to estimate agreement between the methods. The strength of agreement of kappa coefficients was guided by the boundaries suggested by Landis and Koch [22]. Values less than 0 indicate "poor" reliability, 0–0.20 is "slight" reliability, 0.21–0.40 is "fair" reliability, 0.41–0.60 is "moderate" reliability, 0.61–0.80 is "substantial" agreement, 0.81–1.00 "excellent" or "almost perfect" agreement. The p value is considered significant if < 0.05 at confidence interval 95%.

Results

The current study included eighty-three patients with urinary bladder carcinoma. The demographic data, and clinical presentation of the included patients are illustrated in Table 2. The mean age of the studied patients was 65.7 years, and most of the cases (75.9%) were males. Most of the included patients (68.7%) were presented with hematuria, 19.3% had lower urinary tract symptoms, and 12% were accidentally discovered to have bladder cancer during routine ultrasonography.

Table 2 Demographic and clinical characteristics of the studied patients
Full size table

The radiological assessment of the included patients revealed that the posterior and lateral walls were the most common sites of bladder lesions. Most patients (53%) had a single lesion with the polypoid fungating mass as the most common morphology of encountered lesions (77.1%). The most common radiological stage observed was T2 (33.7% of the cases). In terms of lymph node involvement (N), the most prevalent stage was N0 (78.3% of the cases) and most of the cases (97.6%) exhibit no distant metastasis (M0). Most cases (54.2%) underwent TURBT. The mean time of operation was 12.6 ± 11.4 days after MRI as shown in Table 3.

Table 3 MRI and pathological characteristics of the studied patients
Full size table

Regarding the pathological results of the performed biopsies, the most common pathological type was transitional/urothelial carcinoma (86.7%), followed by squamous cell carcinoma (13.3%). Most patients (79.5%) had high grade of carcinoma while the most common pathological stage (T) observed in the provided data was T2 (31.3% of the cases). In terms of lymph node involvement (N), the most prevalent stage was N0 (81.9% of the cases). Additionally, most of the cases (95.2%) had no evidence of distant metastasis (M0). Among the cases, 67.5% were classified as Muscle-invasive bladder cancer (MIBC) including those with stage T2 or more, while 32.5% were categorized as non-muscle-invasive bladder cancer (NMIBC) including stage T1. Hence, the included patients were further subdivided into two groups MIBC and NIMBC as in Table 3.

Significant differences between the studied groups were observed in the type and the time of operation after MRI performance. All patients in the NMIBC group underwent TURBT, while most patients in the MIBC group (67.9%) underwent radical cystectomy (p < 0.001). Regarding the time of operation after MRI performance, the MIBC group had a significantly longer waiting period compared to the NMIBC group (p = 0.015). According to the pathology of performed biopsies in both groups, MIBC group had a higher proportion of high-grade tumors (87.5%) compared to the NMIBC group (63%), with (p = 0.009) (Table 3).

The IVIM MRI and ADC parameters were evaluated in all included patients and then compared between both studied groups. The mass D, mass ADC and wall beside mass D values were significantly lower among MIBC group compared to the NMIBC group, with (p values < 0.001, 0.001 and 0.006), respectively. In MIBC, mass ADC (0.9 × 10−3 mm2/s), mass D (0.8 × 10−3 mm2/s), mass D* (6.9 × 10−3 mm2/s) and mass F (16.9%). In NMIBC, ADC (1 × 10−3 mm2/s), D (1.1 × 10−3 mm2/s), D* (10.2 × 10−3 mm2/s) and F (17.7%) (Table 4 and Fig. 4).

Table 4 bpMRI parameters (IVIM and ADC) in the studied groups
Full size table
Fig. 4
figure 4

Boxplots show the difference between MIBC and NMIBC according to the Mass D, ADC, and wall beside mass D in the studied groups with P values < 0.001, 0.001 and 0.006, respectively. MIBC muscle invasive bladder cancer, NMIBC non-muscle invasive bladder cancer, D true diffusion coefficient, ADC apparent diffusion coefficient standard

Full size image

ROC curve analysis was performed for discrimination between the two studied groups according to MRI-IVIM and ADC parameters. While mass D showed high accuracy (AUC = 0.945), the mass ADC showed moderate accuracy (AUC = 0.721). However, the wall beside mass D showed low accuracy (AUC = 0.686), for discrimination between NMIBC from MIBC. Mass D cut off values, sensitivity and specificity were < 0.9, 83.93 and 96.30, respectively. Mass ADC cut off values, sensitivity and specificity were < 1.09, 87.50 and 51.85, respectively (Table 5 and Fig. 5).

Table 5 Results of the ROC analyses for discriminating NMIBC from MIBC
Full size table
Fig. 5
figure 5

ROC curve of Mass D, ADC and wall beside mass D for Discriminating MIBC From NMIBC. MIBC muscle invasive bladder cancer, NMIBC non-muscle invasive bladder cancer, ROC receiver operating characteristic, AUC area under ROC curve, CI confidence interval, *Significant < 0.05

Full size image

The degree of agreement between the bpMRI and pathological staging was evaluated by the Kappa agreement as shown in Table 6 and Fig. 6. As regards T stages, they were 55.6%, 53.8%, 80.0% and 70.0% for stages T1, T2, T3 and T4, respectively, with a kappa agreement value of 0.489, indicating a moderate overall agreement in T staging. While the degree of agreement in N stages revealed that N0, N1, N2 and N3 had agreement percentages of 82.4%, 42.9%, 25.0% and 0.0%, respectively, with a kappa agreement value of 0.223, indicating a fair overall agreement in N staging. For the M stages, the agreement percentage for M0 and M1 were 97.5%, and 0.0%, respectively, with a kappa agreement value of -0.033, indicating a slight disagreement between radiology and pathology staging for M stages. Furthermore, the degree of agreement between IVIM parameters and the pathological staging was evaluated by Kappa test. The best agreement was detected for mass D, substantial agreement (K = 0.796), while the mass ADC and wall beside mass D showed moderate and fair agreement (k = 0.418 and 0.325, respectively).

Table 6 Agreement between IVIM parameters and pathological staging
Full size table
Fig. 6
figure 6

Degree of agreement between bpMRI and pathological staging. A degree of agreement between radiological and pathological T staging, B agreement in N staging, C degree of agreement in M staging, D agreement between significant IVIM parameters and pathological staging. MIBC muscle invasive bladder cancer, NMIBC non-muscle invasive bladder cancer, D true diffusion coefficient, ADC apparent diffusion coefficient standard

Full size image

Discussion

Bladder cancer is the sixth most common cancer [23]. The main classification for bladder cancers is NMIBC vs. MIBC [24]. Cystoscopy is the commonest tool for diagnosing and treating bladder cancer, allowing direct access to a tumor for biopsy and/or resection [25]. The standard treatment is transurethral resection for NMIBC and radical cystectomy and neoadjuvant chemotherapy for MIBC [26].

The differentiation between MIBC and NMIBC is crucial. It determines the plan of therapy as well as the patient’s prognosis. So, we conducted the current study to evaluate the value of IVIM MRI parameters and ADC values in differentiating MIBC and NMIBC as the data available regarding IVIM in bladder cancer is limited.

This study was conducted on eighty-three patients with urinary bladder carcinoma. All included cases underwent TURBT as diagnostic and therapeutic intervention for NMIBC and diagnostic one for MIBC before proceeding to radical cystectomy and either ileal loop conduit or W-shaped ileal orthotopic neobladder. The pathological staging in our cohort revealed that NMIBC (stage 1) was presented in 32.5% of the cases, while MIBC (stage 2 or more) represented 67.5% of the cases. Forty-five (54.2%) patients operated by TURBT and thirty-eight patient (45.8%) by radical cystectomy,

MRI differentiates the bladder wall layers and enables an accurate assessment of the depth of tumor invasion and extravesical extension [27]. MRI provides anatomical and physiological images for qualitative evaluation and allows for the measurement of model-based quantitative parameters [28]. Quantitative parameters derived from DWI enable numerical values that promise improvements in detecting, staging, and evaluating treatment response in bladder cancer [29]. DWI-derived parameters include the apparent diffusion coefficient (ADC, the composite of both diffusion and capillary perfusion) and true diffusion coefficient (D, capturing tumor cellularity, extracellular-space tortuosity, and integrity of cellular membranes) [30]. The acquisition, interpretation, and reporting of mpMRI for bladder cancer were standardized by Vesical Imaging–Reporting and Data System (VI-RADS) [31]. VI-RADS’s scoring comprises T2-WI, DWI, and DCE-MRI as a qualitative assessment for diagnostic reporting [32]. The dominant MRI sequence for bladder cancer risk assessment is DWI. If DWI-MRI is suboptimal, DCE-MRI is considered a second option [32].

In our study, we used T2WI and IVIM MRI in biparametric MRI protocol for staging of urinary bladder carcinoma (VI-RADS). T2WI and DWI were used for qualitative evaluation, ADC values and IVIM parameter (D, D* & F) were used for quantitative evaluation. We found that the moderate overall agreement between radiological and pathological staging of the tumor in addition to the substantial agreement between mass D value and pathological classification. This indicates that IVIM parameters especially mass D value is a valuable tool to predict the aggressiveness of bladder cancer and can guide the plan of therapy.

Regarding IVIM parameters, we found that MIBC had lower values of mass D and wall beside mass D compared to NMIBC, with p values < 0.001 and 0.006, respectively. Moreover, in the context of ADC values, MIBC had lower ADC values than NMIBC. However, the D* and f values did not differ between both groups. Regarding the sensitivity and specificity of different IVIM parameters, the D value has significantly larger AUC than that of ADC. The D value has 83.93% sensitivity and 96.3% specificity while ADC has 87.5% sensitivity and 51.85% specificity. The best combination of parameters was combined D and ADC values.

In line with our results, Wang et al. reported that the ADC and D value were significantly lower in patients with MIBC compared to those with NMIBC (P < 0.01). No significant differences were observed in D* and f. The AUC of D value (0.894) was significantly larger than the ADC value (0.786), with sensitivities and specificities of 95% and 87.5% for (D) and 80% and 68.7% for (ADC), respectively. In addition, the D and ADC values were significantly correlated with Ki-67 LI (r = –0.785, r = –0.643, respectively; both P < 0.01) [33].

We agree with Akin et al. who reported that Qualitative and quantitative MRI offer excellent contrast resolution for preoperative staging for bladder cancer [34]. Also, we agree with Johi et al. who suggested that adding DWI-derived parameters to T2WI improves the accuracy of MRI in bladder cancer detection and staging; staging accuracy was better in T2WI plus DWI-MRI (83%) as compared to DW-MRI alone (77%) or T2WI alone (75%) [34].

In contrary to our results, Zhang et al., reported that the ADC and D values differed significantly among low, intermediate, and high‐aggressive urothelial bladder carcinomas (P < 0.05). However, the f values showed significant difference when compared between low and high‐aggressive or intermediate and high‐aggressive bladder carcinomas (P < 0.05). The best parameter for differentiating high from low/intermediate aggressive urothelial bladder carcinoma was ADC value, with the AUC and accuracy of 0.895 and 85.97%, respectively. Moreover, the f and D values had AUCs of 0.873 and 0.862, respectively. The best differentiating parameter was combination of D and f values, with AUC of 0.931 and 91.82%, accuracy [35].

Limitations of the current study

There are some limitations of the present study as being a single center study and obtaining the analyzed parameters from single region of interest (ROI) that may not fully reflect the information of the whole tumor. Moreover, we did not use IV contrast, so our research is considered biparametric not multi-parametric study, and the sample size is comparatively small. In addition, MRI examination may be amenable to patient motion or bladder catheter artifacts which were encountered in few cases. Despite these limitations, our results provide important new insight into the emerging role of IVIM-MRI in diagnosis and staging of UB carcinoma.

Conclusions

IVIM MRI and ADC can add more information in evaluation of bladder cancer. They can help in staging and grading of bladder cancer as well as their precious role in follow up and thus combination of such functional sequences should be advocated whenever differentiation between superficial and muscle invasive disease during preoperative workup and post-operative follow up is required. Mass D showed higher accuracy for discrimination between NMIBC From MIBC than Mass ADC. The best cut-off values and performance characteristics of mass D, mass ADC and wall beside mass D were < 0.9, < 1.09 and < 0.97, respectively. Although the current study included quite enough cases, further multicenter studies on larger sample size may be beneficial to confirm our data.

Availability of data and materials

The datasets used and/or analyzed are available from the corresponding author on reasonable request.

Abbreviations

ADC:

Apparent diffusion coefficient

bpMRI:

Biparametric MRI

D:

True diffusion coefficient

D*:

Pseudodiffusion coefficient

DWI:

Diffusion-weighted imaging

DCE:

Dynamic contrast enhancement

f:

Perfusion fraction

IVIM:

Intravoxel incoherent motion

MIBC:

Muscle-invasive bladder cancers

MRI:

Magnetic resonant imaging

NMIBC:

Non-muscle-invasive bladder cancers

ROI:

Region of interest

TURBT:

Transurethral resection of bladder tumor

References

  1. Kumar N, Talwar R, Nandy PR (2017) Efficacy of voided urinary cytology and ultrasonography compared to cystoscopy in the detection of urinary bladder cancer. African Journal of Urology 23(3):192–196

    Article  Google Scholar 

  2. Moussa S, El-Sheshtawy W (2017) Pathological pattern of urinary bladder cancer: data from a single Egyptian Institute. Res Oncol 13(1):14–17

    Article  Google Scholar 

  3. Martingano P, Stacul F, Cavallaro M, Casagrande F, Cernic S, Belgrano M et al (2010) 64-Slice CT urography: 30 months of clinical experience. Radiol Med (Torino) 115(6):920–935

    Article  CAS  PubMed  Google Scholar 

  4. Richards KA, Smith ND, Steinberg GD (2014) The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. J Urol 191(6):1655–1664

    Article  PubMed  Google Scholar 

  5. Milowsky MI, Rumble RB, Booth CM, Gilligan T, Eapen LJ, Hauke RJ et al (2016) Guideline on muscle-invasive and metastatic bladder cancer (European Association of Urology guideline): American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 34(16):1945–1952

    Article  PubMed  Google Scholar 

  6. Wang H, Pui MH, Guo Y, Li S, Guan J, Zhang X et al (2015) Multiparametric 3-T MRI for differentiating low-versus high-grade and category T1 versus T2 bladder urothelial carcinoma. Am J Roentgenol 204(2):330–334

    Article  Google Scholar 

  7. Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ et al (2007) Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 51(1):137–151

    Article  PubMed  Google Scholar 

  8. Takeuchi M, Sasaki S, Naiki T, Kawai N, Kohri K, Hara M et al (2013) MR imaging of urinary bladder cancer for T-staging: a review and a pictorial essay of diffusion-weighted imaging. J Magn Reson Imaging 38(6):1299–1309

    Article  PubMed  Google Scholar 

  9. Gupta N, Sureka B, Kumar MM, Malik A, Bhushan TB, Mohanty NJ (2015) Comparison of dynamic contrast-enhanced and diffusion weighted magnetic resonance image in staging and grading of carcinoma bladder with histopathological correlation. Urol Ann 7(2):199

    Article  PubMed  PubMed Central  Google Scholar 

  10. Badawy M, Farg H, Gadelhak B, ElGhar MA, Sadeq AG, Borg MJ et al (2020) Diagnostic performance of 3-tesla multiparametric MRI for assessment of the bladder cancer t stage and histologic grade. Egypt J Radiol Nucl Med 51(1):1–11

    Article  Google Scholar 

  11. El-Assmy A, Abou-El-Ghar ME, Mosbah A, El-Nahas AR, Refaie HF, Hekal IA et al (2009) Bladder tumour staging: comparison of diffusion-and T2-weighted MR imaging. Eur Radiol 19(7):1575–1581

    Article  PubMed  Google Scholar 

  12. Yoshida S, Koga F, Masuda H, Fujii Y, Kihara KJ (2014) Role of diffusion-weighted magnetic resonance imaging as an imaging biomarker of urothelial carcinoma. Int J Urol 21(12):1190–1200

    Article  PubMed  Google Scholar 

  13. Lin W-C, Chen J-H (2015) Pitfalls and limitations of diffusion-weighted magnetic resonance imaging in the diagnosis of urinary bladder cancer. Transl Oncol 8(3):217–230

    Article  MathSciNet  PubMed  PubMed Central  Google Scholar 

  14. Le Bihan D, Breton E, Lallemand D, Aubin M, Vignaud J, Laval-Jeantet MJR (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168(2):497–505

    Article  PubMed  Google Scholar 

  15. Shen N, Zhao L, Jiang J, Jiang R, Su C, Zhang S et al (2016) Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion. J Magn Reson Imaging 44(3):620–632

    Article  PubMed  Google Scholar 

  16. Granata V, Fusco R, Catalano O, Guarino B, Granata F, Tatangelo F et al (2016) Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for Hepatocellular carcinoma: correlation with histologic grade. Oncotarget 7(48):79357

    Article  PubMed  PubMed Central  Google Scholar 

  17. Yuan J, Wong OL, Lo GG, Chan HH, Wong TT, Cheung PS et al (2016) Statistical assessment of bi-exponential diffusion weighted imaging signal characteristics induced by intravoxel incoherent motion in malignant breast tumors. Quant Imaging Med Surg 6(4):418

    Article  PubMed  PubMed Central  Google Scholar 

  18. Zhu HB, Zhang XY, Zhou XH, Li XT, Liu YL, Wang S et al (2017) Assessment of pathological complete response to preoperative chemoradiotherapy by means of multiple mathematical models of diffusion-weighted MRI in locally advanced rectal cancer: a prospective single-center study. J Magn Reson Imaging 46(1):175–178

    Article  PubMed  Google Scholar 

  19. Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ et al (2013) Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med 69(2):553–562

    Article  PubMed  Google Scholar 

  20. Malagi AV, Das CJ, Khare K, Calamante F, Mehndiratta A (2019) Effect of combination and number of b values in IVIM analysis with post-processing methodology: simulation and clinical study. Magn Reson Mater Phys Biol Med 32:519–527

    Article  Google Scholar 

  21. Pan J, Zhang H, Man F, Shen Y, Wang Y, Zhong Y et al (2018) Measurement and scan reproducibility of parameters of intravoxel incoherent motion in renal tumor and normal renal parenchyma: a preliminary research at 30 T MR. Abdom Radiol 43:1739–1748

    Article  Google Scholar 

  22. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 1977:159–174

    Article  Google Scholar 

  23. Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. Ca Cancer J Clin 73(1):17–48

    Article  PubMed  Google Scholar 

  24. Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD et al (2017) Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171(3):540–556

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Tholomier C, Souhami L, Kassouf W (2020) Bladder-sparing protocols in the treatment of muscle-invasive bladder cancer. Transl Androl Urol 9(6):2920

    Article  PubMed  PubMed Central  Google Scholar 

  26. Tanaka H, Kijima T, Fujii Y (2020) Bladder preservation therapy in muscle-invasive bladder cancer: Current evidence and future perspectives. AME Med J

  27. Li Q, Cao B, Tan Q, Liu K, Jiang S, Zhou J (2021) Prediction of muscle invasion of bladder cancer: a comparison between DKI and conventional DWI. Eur J Radiol 136:109522

    Article  PubMed  Google Scholar 

  28. Donaldson SB, Bonington SC, Kershaw LE, Cowan R, Lyons J, Elliott T et al (2013) Dynamic contrast-enhanced MRI in patients with muscle-invasive transitional cell carcinoma of the bladder can distinguish between residual tumour and post-chemotherapy effect. Eur J Radiol 82(12):2161–2168

    Article  PubMed  Google Scholar 

  29. Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S et al (2018) Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 74(3):294–306

    Article  PubMed  PubMed Central  Google Scholar 

  30. Panebianco V, Narumi Y, Barchetti G, Montironi R, Catto JWF (2019) Should we perform multiparametric magnetic resonance imaging of the bladder before transurethral resection of bladder? Time to reconsider the rules. Eur Urol 76(1):57–58

    Article  PubMed  Google Scholar 

  31. Panebianco V, Pecoraro M, Del Giudice F, Takeuchi M, Muglia VF, Messina E et al (2022) VI-RADS for bladder cancer: current applications and future developments. J Magn Reson Imaging 55(1):23–36

    Article  PubMed  Google Scholar 

  32. Zhang X, Wang Y, Zhang J, Zhang L, Wang S, Chen Y (2022) Development of a MRI-based radiomics nomogram for prediction of response of patients with muscle-invasive bladder cancer to neoadjuvant chemotherapy. Front Oncol 12:878499

    Article  PubMed  PubMed Central  Google Scholar 

  33. Wang F, Wu LM, Hua XL, Zhao ZZ, Chen XX, Xu JR (2018) Intravoxel incoherent motion diffusion-weighted imaging in assessing bladder cancer invasiveness and cell proliferation. J Magn Reson Imaging 47(4):1054–1060

    Article  PubMed  Google Scholar 

  34. Al Johi RS, Seifeldein GS, Moeen AM, Aboulhagag NA, Moussa EM, Hameed DA et al (2018) Diffusion weighted magnetic resonance imaging in bladder cancer, is it time to replace biopsy? Central Eur J Urol 71(1):31

    Google Scholar 

  35. Zhang M, Chen Y, Cong X, Zhao X (2018) Utility of intravoxel incoherent motion MRI derived parameters for prediction of aggressiveness in urothelial bladder carcinoma. J Magn Reson Imaging 48(6):1648–1656

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge all members of the Radiology Department in Urology and Nephrology Center, Mansoura University, Egypt.

Funding

No funding resources were received for the current study.

Author information

Authors and Affiliations

  1. Diagnostic Radiology and Medical Imaging, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt

    Mohamed Ali Badawy & Mona S. Korkor

  2. Diagnostic Radiology and Medical Imaging, Faculty of Medicine, Mansoura University, Mansoura, Egypt

    Samia Mounir Zaky & Sherif Abdel Fattah

Authors
  1. Mohamed Ali Badawy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samia Mounir Zaky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mona S. Korkor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sherif Abdel Fattah
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M.K. contributed to the data collection. M.K. and M.B. performed data analysis and writing. M.B., S.Z. and S.A. performed supervision. They all approved the final version of the manuscript.

Corresponding author

Correspondence to Mona S. Korkor.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Research Ethics Committee of the Faculty of Medicine at Mansoura University in Egypt on 30/01/2023; reference number of approval: (MS.23.01.2275.R1).

Consent for participation

Informed consent was obtained from all patients prior to inclusion in the study.

Consent for publication

Not applicable (no identifying information about participants is available in the article).

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Badawy, M.A., Zaky, S.M., Korkor, M.S. et al. Role of intravoxel incoherent motion MRI in diagnosis and assessment of invasiveness of urothelial bladder carcinoma. Egypt J Radiol Nucl Med 55, 40 (2024). https://doi.org/10.1186/s43055-024-01212-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43055-024-01212-3

Keywords